Annual Meeting Proceedings Part 1 - American Society of Clinical ...

2012 ASCO Annual Meeting Proceedings Plenary Session
5s
LBA1 Plenary Session, Sun, 1:00 PM-4:00 PM
Primary results from EMILIA, a phase III study of trastuzumab emtansine
(T-DM1) versus capecitabine (X) and lapatinib (L) in HER2-positive locally
advanced or metastatic breast cancer (MBC) previously treated with
trastuzumab (T) and a taxane. Presenting Author: Kimberly L. Blackwell,
Duke University Medical Center, Durham, NC
The full, final text of this abstract will be available at
abstract.asco.org at 12:01 AM (EDT) on Sunday, June 3,
2012, and in the Annual Meeting Proceedings online
supplement to the June 20, 2012, issue of Journal of
Clinical Oncology. Onsite at the Meeting, this abstract will
be printed in the Sunday edition of ASCO Daily News.
ABSTRACTS
The American Society of Clinical Oncology
48th Annual Meeting
June 1-5, 2012
McCormick Place
Chicago, Illinois
2 Plenary Session, Sun, 1:00 PM-4:00 PM
Long-term follow-up results of EORTC 26951: A randomized phase III
study on adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors
(AOD). Presenting Author: Martin J. Van Den Bent, Erasmus University
Medical Center, Daniel den Hoed Cancer Center, Rotterdam, Netherlands
The full, final text of this abstract will be available at
abstract.asco.org at 12:01 AM (EDT) on Sunday, June 3,
2012, and in the Annual Meeting Proceedings online
supplement to the June 20, 2012, issue of Journal of
Clinical Oncology. Onsite at the Meeting, this abstract will
be printed in the Sunday edition of ASCO Daily News.
Visit abstract.asco.org and search by abstract for the full list of abstract authors and their disclosure information.